Overview

Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

This is a phase 1 study to evaluate the safety and effectiveness of using the Litx™ BPH System in patients with LUTS due to benign prostatic hyperplasia (BPH).

Phase:

Phase 1

Details

Lead Sponsor:

Light Sciences Oncology

Treatments:

Talaporfin